Daniel M. Anderson
Principal investigator
Medical oncologist and hematologist
HealthPartners Research Foundation
United States of America
Biography
Daniel M. Anderson is a Principal investigator and Assistant Professor, Department of Hematology, Oncology and Transplantation, University of Minnesota.Dr. Anderson has completed training in clinical cancer research and is currently working on projects investigating the effectiveness of current therapies in treating patients with advanced cancers. Dr. Anderson's work has been published in journals such as the Annals of Oncology and the Journal of Clinical Oncology. He was also a featured physician in "American Heart," a documentary that explored health care through the eyes of refugees living in the American heartland.
Research Interest
Dr. Anderson became interested in working with people with cancer because of the unique relationships he has developed with them. He also enjoys the intellectual challenge of working with patients who have blood and clotting disorders. He is a member of the American Society of Hematology, American Society of Clinical Oncology, American Association for Cancer Research and Minnesota Society of Clinical Oncology.
Publications
-
Anderson DM1, Rolnick SJ, Jackson J, Amundson J, Asche SE, et al., (2007)Impact of chemotherapy in women with metastatic breast cancer diagnosed 1990-2003. Clin Breast Cancer. 7:801-803.
-
Jackson JM, Anderson DM, Butani AL, Asche SE, Rolnick SJ (2008)Statin use is associated with a reduced risk of colon cancer recurrence. Advancing Research and Clinical Care.
-
Tan WW1, Hillman DW, Salim M, Northfelt DW, Anderson DM, et al., (2010)N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial. Ann Oncol. 21:493-497.
-
Park H, Qin R, Smith TJ, Atherton PJ, Barton DL (2015)North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause. 22:627-632
-
Yoon HH, Bendell JC, Braiteh FS, Firdaus I, Philip PA (2016)Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial. Ann Oncol 27:2196-2203.
